Melwin TP (He/Him)

Execute the ideas that drive recruiting. Sourcer - Recruiter - Leadership Hiring - DEI Hiring. Working in an e-commerce company. Tweets are personal.

[Melwin TP (He/Him) @MelwinP]

@TruthNo_7 Wish you a speedy recovery.

[Melwin TP (He/Him) @MelwinP]

@IndianGems_ The need of the hour is a pot hole free road and we are aiming at something that is possible in 2047

[Melwin TP (He/Him) @MelwinP]

@meenakshei Felt the same, nayanthara was a complete misfit for this role. I don't understand when some of the reviews mentioned that it's a feel good movie, for the few minutes in to the movie I felt its a disaster.

[TheLiverDoc™ @theliverdoc]

PLEASE READ. THIS IS IMPORTANT. SEE HOW YOUR TAX MONEY IS WASTED ON FRAUD PSEUDOSCIENCE STUDIES BY THE BJP GOVERNMENT.

The study did not demonstrate added benefit, and its claim of prolonged safety is a lie.

No demonstrated benefit
Ashwagandha did not produce a statistically convincing improvement in antibody responses, COVID-19 prevention or quality of life. There were 27 infections among 598 Ashwagandha recipients and 20 among 602 placebo recipients. This does not demonstrate protection.

Some numbers are mathematically impossible
The same supplement reports a spread (standard deviation) of 13.8 for a questionnaire score that mathematically cannot have a spread larger than about 10.8–12 — like reporting that everyone in a room is between 5 and 6 feet tall, with an average variation of 2 feet. Elsewhere, the placebo group’s heights supposedly vary by 17–22 cm while every other group varies by 9–10 cm; the odds of that happening in a real randomized trial are about one in a trillion trillion trillion.

The one “positive” result is an illusion created by math
The abstract says the Ashwagandha group showed “persistently higher” antibody levels in one subgroup. The paper’s own Table 2 shows the opposite: that group’s actual antibody levels were lower at every single time point. The “20–40% higher” claim comes from measuring change from each group’s starting point — and the Ashwagandha group happened to start 25–34% lower, so its catch-up looks bigger as a percentage. It is like two runners: one starts 10 metres behind and both finish together; you then praise the trailing runner for “gaining more metres.” That is not a drug effect; it is an accounting artifact. The paper never tells readers this.

The safety story is a lie and the bad bits were left out
“Safe” in this paper means “no statistically proven difference in harms” - but the trial was not designed to detect rare or moderate harms, and every actual number tilts against the herb: more adverse events (337 vs 309), more serious adverse events (6 vs 2), more probably drug-related events (7 vs 2), and more dropouts (92 vs 76) in the Ashwagandha arm. Some numbers were simply misreported: serious reactions are listed as “0.08%” when the real figure is 0.67% - ten times higher. Significant differences in blood tests (including D-dimer, a clotting marker that matters after an adenovirus-based vaccine like Covishield) appear in the tables but are never mentioned in the text, which instead says all lab results stayed normal. And 168 people (14%) left the trial for “various reasons” that are never itemized, so the claim that “no one quit because of side effects” cannot be checked.

Basic numbers and statistical tests do not agree.
Nobody can say how many people were actually in the trial. The text reports 11 symptomatic COVID-19 infections, while the adverse-event table reports 22. Depending on which table you read, the same 1,200 participants split into subgroups four different, mutually contradictory ways (the totals come out as 1,200, 1,194, 1,019-labelled-as-919, and 1,025). One trial cannot have four different headcounts. Dropout rates also varied bizarrely between recruitment waves - 23.7% in one group versus 5.4% in another, with no explanation. Some statistical test results cannot be reproduced from the printed counts.

Some laboratory data require urgent verification. Some of the data were literally copied and pasted.
In the paper’s quality-of-life supplement, one column of numbers (baseline results for the Ashwagandha group) reappears — digit for digit, all eight values — as a completely different column (week-28 results for the placebo group). Two different groups of people, measured six months apart, do not produce identical results down to the second decimal place. This is a copy-paste job, and it means at least one of those columns is not real data. One table reports a very large difference in blood urea between groups, with small variation within each group, yet gives a statistical result suggesting little difference. The corresponding urea-nitrogen value also does not fit. In the quality-of-life supplement, four pairs of averages and measures of variation are repeated exactly across different groups and visits.

Ashwagandha's quality documents do not consistently support their own claims.
A raw-root test reports 0.048% total alkaloids against its stated minimum of 0.3%, while declaring compliance. Those statements cannot all be correct. The extract and finished-tablet measurements also do not reconcile on the obvious calculation. Chromatograms dated 2019 are supplied for a trial that began enrolling in late 2021, without showing their connection to the actual trial batches. This means the documentation is insufficient to verify what participants received.

The goalposts were moved after the results came in
When the trial was registered in 2021, its main question was whether Ashwagandha improves the immune response to the vaccine. The answer came back: no measurable effect. So the published paper re-centred itself on a secondary question — safety — and put “safe” in the title, while demoting the original main question to “exploratory.” That is called outcome switching, and trial registration exists precisely to prevent it. Along the way, the eligible age range quietly changed three times across documents (18–45, then 18–65, then 18–70), a planned interim analysis vanished, and the timeline described in the paper contradicts the registry.

The paper hid the fact that the two groups were not comparable
A fair trial needs the treated group and the placebo group to start out the same. At the start of this trial, 77.6% of the placebo group had signs of a past COVID infection, versus 70.9% of the Ashwagandha group — a real, statistically significant difference (the correct p-value is about 0.01). The paper’s own Table 1 says so. But the text of the paper claims the groups were “comparable” and quotes a p-value of 0.50 - wrong by a factor of fifty, and wrong in the direction that hides the problem. Why it matters: the group with fewer past infections (Ashwagandha) would be expected to look different on later antibody tests anyway, which muddies every comparison the paper makes about immunity and breakthrough infections.

The published paper contains fabricated-looking data blocks, impossible statistics, a fifty-fold misreported p-value that hides an unfair comparison, a main result replaced by a secondary one after the fact, and a headline “benefit” that its own tables disprove.
https://t.co/jXY9Q75PMM

A letter to the journal's Science Integrity Department WILL BE MAILED TODAY with the following concerns about this paper @FrontiersIn

[Melwin TP (He/Him) @MelwinP]

@tds122 Umesh Yadav

[Melwin TP (He/Him) @MelwinP]

@itsmeStAbhi Seeing on the big screen gave me goose bumps and that elevation in the BGM was on another level.

[pa.ranjith @beemji]

The origin of Sarpatta Parambarai begins 🥊
#SarpattaParambaraiRound2
#SP2 💥

[MANJUL @MANJULtoons]

Instagram has restricted this cartoon in India.

I am posting the cartoon again, along with the notice I received from Instagram.

According to the notice, access has been restricted in India “pursuant to a notice from the Government of India / Law Enforcement” and based on local laws.

The cartoon is still visible outside India.

A cartoon about the Election Commission has been stopped from being seen by Indians. When satire gets censored, perhaps the cartoon has made its point. 🇮🇳

#Censorship #FreeSpeech #Satire #PoliticalCartoon #FreedomOfExpression #ElectionCommission #MANJULtoons

[Sandeep Manudhane @sandeep_PT]

A fake name handle with a fake picture being run from the US (& controlled by Indian regime) is finally telling the supporters of regime "you don't matter" 😹

[Melwin TP (He/Him) @MelwinP]

@baldwhiner When people are treated like dogs, then this is to happen.

[Melwin TP (He/Him) @MelwinP]

@baldwhiner Why are they doing this?

[Melwin TP (He/Him) @MelwinP]

@asuph Everything.

[Melwin TP (He/Him) @MelwinP]

@manoj_216 Let him enjoy the time.

[Melwin TP (He/Him) @MelwinP]

@MTPHereToHelp @CyrusDhabhar May be next time sir

[Karthik 🇮🇳 @beastoftraal]

This!! 🎯

[Dr. Prince Verma @PrinceV93789344]

Just read this post from @talk2anuradha.
The sheer stupidity is staggering.
A basic Google reverse image search is all it takes to prove that “house” is a commercial Kerala resort or homestay in Pathanamthitta , not some modest family home belonging to her mythical ST friend who supposedly leveraged reservation for NIT, a PSU job, and then IIM.
She fabricated an entire sob-story around a tourist property and expected no one to notice.
The “liar gene” is strong with this one. 🧬 👇👇 🤡😂

[Joy @Joydas]

I see many well meaning people saying Opposition should boycott elections. They have said before also. This sounds logical and effective only if you are naive enough to believe the ruling party, EC, Courts etc in current dispensation are entities with strong principles and a moral compass.

In reality, what will happen is that all Opposition will boycott elections, the Ruling Party will put multiple independent candidates in all seats, EC will say there are candidates contesting, so elections are happening and Court will say we can’t force anyone to participate in elections, you all voluntarily decided to boycott what can we do. In the end, the Ruling Party will win almost all seats, have official legitimacy and pass whatever bills they want. They can even junk the constitution.

The Opposition currently, though smaller in number, fragmented, is still numbers in the parliament. And they have put the fight and made the Government backtrack. Latest was delimitation bill. So the solution is not in opposition boycott of elections.

[CS Amudhan @csamudhan]

I haven’t seen Dorothy, but the vile propaganda that’s being dumped on it because it could have LGBTQ themes is shameful. Come on TN we still have some cred as a liberal state, we can be better. I’ll be watching Dorothy tomorrow. I ask that you should too.

[TheLiverDoc™ @theliverdoc]

So a group of people who do not deserve to be in authority, weaponized a brainwashed section of low critically thinking individuals, stole powers, used that to rig the system, and shamelessly held on to purchased power, while everything from harmony to healthcare was destroyed for appeasement. Really, evil stuff. What next?

[Abijit Ganguly @AbijitG]

The biggest win of BJP has been to convince it's hardcore followers that anyone opposing them are part of this major global-funded toolkit or something. It's so hilarious if you think of it. Bhai tum duniya ke sabse rayees political party ho. Har jagah tum advertisements post kare jaa rahe ho. Birthday tum aise mana rahe ho jaise Diwali ho. American isharo pe ta thaiya tum kar rahe ho. Baaki saare parties nange se pade hai bina paise ke. Par apne logo ko mana rakha hai ki hum kisi se kuch paise deke nahi bulwa rahe, yeh bure log aise kar rahe hai.
Sahi hai bhai.